首页 > 市场调查报告书 > 製药

处方药

市场调查报告书

商品编码

2008125

Flumazenil市场：按剂量、应用、分销管道和地区划分

Flumazenil Market, By Dose, By Application, By Distribution Channel, By Geography

出版日期: 2026年03月18日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年Flumazenil市场规模估计为2,170万美元，预计到2033年将达到2,880万美元。预计2026年至2033年，其复合年增长率将达6.2%。

分析范围		分析详情
基准年	2025	市场规模（2026 年）	2170万美元
效能数据	2020-2024	预测期	2026-2033
预测期（2026-2033 年）复合年增长率	6.20%	预计金额（2033 年）	2880万美元

Flumazenil是一种苯二氮平拮抗剂，用于解救Flumazenil麻醉剂引起的术后镇静。Flumazenil注射剂建议用于完全或部分逆转成人和儿童在清醒镇静和全身麻醉中苯二氮平类药物的镇静作用。

Flumazenil也适用于成人苯二氮平类药物过量的治疗。它用于缓解苯二氮平类药物过量引起的昏迷。Flumazenil在缓解苯二氮平类药物中毒引起的昏迷方面比在缓解多种药物过量引起的昏迷方面更有效。

市场动态

对使用Flumazenil治疗昏迷的研究和开发不断增加，预计将推动全球Flumazenil市场的成长。例如，根据2021年5月9日发表在《医学病例报告杂誌》（Journal of Medical Case Reports）上的研究数据，研究人员报告称，Flumazenil在格拉斯哥昏迷评分（GCS）为15分的患者中显示出良好的神经认知功能完全恢復效果。对于GCS评分为3分且无反应的患者，静脉注射0.25毫克氟Flumazenil后，患者的神经认知功能完全恢復。

在预测期内，越来越多的人面临困倦问题，预计将推动全球Flumazenil市场成长。例如，根据欧洲运输工人联盟公布的数据，2019 年在伦敦进行的一项调查发现，在驾驶人，有 37% 的人表示他们必须克服困倦来保持清醒。Flumazenil用于治疗困倦患者。静脉注射注射Flumazenil治疗嗜睡症状更为有效。

本报告的主要特点

本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本文根据以下参数，介绍了全球Flumazenil市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
《全球Flumazenil市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球Flumazenil市场中使用的各种策略矩阵来促进决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
- 南非
- 中非
- 北非

第八章竞争情势

公司简介
- Hoffmann La Roche
- Akorn-Strides, LLC
- Sandoz Canada Incorporated
- Fresenius Kabi USA, LLC
- Mylan Pharmaceuticals
- Genentech, Inc.
- General Injectables &Vaccines Inc
- Sina Health Inc.
- West Ward Pharmaceutical
- HF Acquisition Co. LLC, DBA HealthFirst
- Hikma Farmaceutica
- Pfizer Laboratories Div Pfizer Inc.
- Physicians Total Care, Inc.
- Bedford Pharmaceuticals

第九章

参考
分析方法

简介目录

Product Code: CMI5187

Flumazenil Market is estimated to be valued at USD 21.7 Mn in 2026 and is expected to reach USD 28.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 21.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.20%	2033 Value Projection:	USD 28.8 Mn

Flumazenil is a benzodiazepine inhibitor Flumazenil are used as reversal drug for postsurgical sedation from benzodiazepine anesthetics. Flumazenil injection is recommended for a complete or partial reversal of the sedative effects of benzodiazepines in conscious sedation and general anesthesia in adult and pediatric populations.

Flumazenil is also designated for the management and treatment of benzodiazepine overdose in adults. It is used in reversing coma due to benzodiazepine overdose. Flumazenil is more effective in reversing coma in benzodiazepine intoxication than patients with multiple drug overdoses.

Market Dynamics

Increasing research and development for the treatment of coma using flumazenil is expected to propel growth of the global flumazenil market. For instance, according to research data published on May 9, 2021, in Journal of Medical Case Reports, researchers have reported that flumazenil has showed positive result in complete neurocognitive recovery of patient with a Glasgow Coma Score of 15. 0.25 mg of flumazenil was intravenously administered to the patient who was unresponsive with Glass Coma Score of 3. After the patient was directed with flumazenil, the patient completely recovered by neurocognitive.

Increasing cases of people facing drowsiness problem is expected to drive growth of the global flumazenil market, over the forecast period. For instance, according to data published by European Transport Workers' Federation, in 2019 a survey done in city of London, reported that among 1353 bus drivers 37% of the drivers had to fight with drowsiness in order to stay awake. Flumazenil is used for the treatment of patients suffering from drowsiness. Flumazenil injections given through vein are more effective to treat people facing drowsiness.

Key features of the study

This report provides an in-depth analysis of the global flumazenil market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global flumazenil market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Hoffmann La Roche, Akorn-Strides, LLC, Sandoz Canada Incorporated, Fresenius Kabi USA, LLC, Mylan Pharmaceuticals, Genentech, Inc., General Injectables & Vaccines Inc, Sina Health Inc, West Ward Pharmaceutical, HF Acquisition Co. LLC, DBA HealthFirst, Hikma Farmaceutica, Pfizer Laboratories Div Pfizer Inc., Physicians Total Care, Inc., and Bedford Pharmaceuticals
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global flumazenil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flumazenil market.

Market Segmentation

By Dose
- 5 ml
- 10 ml
By Application
- Anti - Sedation
- Reversing Drowsiness
- Others (Hepatic Encephalopathy, Cirrhosis)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Hoffmann La Roche
- Akorn-Strides, LLC
- Sandoz Canada Incorporated
- Fresenius Kabi USA, LLC
- Mylan Pharmaceuticals
- Genentech, Inc.
- General Injectables & Vaccines Inc
- Sina Health Inc
- West Ward Pharmaceutical
- HF Acquisition Co. LLC
- DBA HealthFirst
- Hikma Farmaceutica
- Pfizer Laboratories Div Pfizer Inc.
- Physicians Total Care, Inc.
- Bedford Pharmaceuticals.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Dose
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Flumazenil Market, By Dose, 2026-2033 (USD Million)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
5 ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
10 ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global Flumazenil Market, By Application, 2026 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Anti - Sedation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Reversing Drowsiness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others (Hepatic Encephalopathy, Cirrhosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Global Flumazenil Market, By Distribution Channel, 2026 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

7. Global Flumazenil Market, By Region, 2026 - 2033 (USD Million)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
- Market Size and Forecast, By Application, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Hoffmann La Roche
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Akorn-Strides, LLC
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sandoz Canada Incorporated
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Fresenius Kabi USA, LLC
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Mylan Pharmaceuticals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Genentech, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- General Injectables & Vaccines Inc
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sina Health Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- West Ward Pharmaceutical
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- HF Acquisition Co. LLC, DBA HealthFirst
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Hikma Farmaceutica
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Pfizer Laboratories Div Pfizer Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Physicians Total Care, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Bedford Pharmaceuticals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

Flumazenil市场：按剂量、应用、分销管道和地区划分

Flumazenil Market, By Dose, By Application, By Distribution Channel, By Geography

市场动态

目录

第一章：分析目标与假设

第二章市场展望

第三章：市场动态、监管与趋势分析

第四章全球Flumazenil市场：依剂量划分（2026-2033 年）

第五章：全球Flumazenil市场：按应用领域划分（2026-2033 年）

第六章：全球Flumazenil市场：依通路划分（2026-2033 年）

第七章全球Flumazenil市场：按地区划分（2026-2033 年）

第八章竞争情势

第九章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Flumazenil Market, By Dose, 2026-2033 (USD Million)

5. Global Flumazenil Market, By Application, 2026 - 2033 (USD Million)

6. Global Flumazenil Market, By Distribution Channel, 2026 - 2033 (USD Million)

7. Global Flumazenil Market, By Region, 2026 - 2033 (USD Million)

8. Competitive Landscape

9. Section

Flumazenil市场：按剂量、应用、分销管道和地区划分

Flumazenil Market, By Dose, By Application, By Distribution Channel, By Geography

市场动态

目录

第一章：分析目标与假设

第二章 市场展望

第三章：市场动态、监管与趋势分析

第四章 全球Flumazenil市场：依剂量划分（2026-2033 年）

第五章：全球Flumazenil市场：按应用领域划分（2026-2033 年）

第六章：全球Flumazenil市场：依通路划分（2026-2033 年）

第七章 全球Flumazenil市场：按地区划分（2026-2033 年）

第八章 竞争情势

第九章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Flumazenil Market, By Dose, 2026-2033 (USD Million)

5. Global Flumazenil Market, By Application, 2026 - 2033 (USD Million)

6. Global Flumazenil Market, By Distribution Channel, 2026 - 2033 (USD Million)

7. Global Flumazenil Market, By Region, 2026 - 2033 (USD Million)

8. Competitive Landscape

9. Section

第二章市场展望

第四章全球Flumazenil市场：依剂量划分（2026-2033 年）

第七章全球Flumazenil市场：按地区划分（2026-2033 年）

第八章竞争情势